Isabelle Hardy, MD, FRCS(C), DABO
Associate Professor, Department of Ophthalmology, University of Montreal
Ophthalmologist, Centre universitaire d’ophtalmologie, Maisonneuve-Rosemont Hospital (CUO-HMR)
Chair, Department of Ophthalmology, University of Montreal
Holder of Suzanne Véronneau-Troutman, M.D., FRCS(C), FACS Chair
Université de Montréal, Montréal, Canada
Cumulating 28 years as an ophthalmologist specialized in oculoplastic, Dr. Hardy graduated from the University of Montreal, where she had completed her medical school studies and her residency in ophthalmology, which was followed by 2 years of specialized training in oculoplastic and orbital surgery at McGill University and at the Fondation Ophtalmologique Adolphe de Rothschild in Paris, France.
Upon her return to the University Montreal, Dr. Hardy actively participates in the development and the promotion of the oculoplastic division. Under her leadership, the University of Montreal has trained more than 19 international fellows in oculoplastic and the surgical team has grown from 3 to more than 10 internationally renowned surgeon-professors.
As Chief of the Ophthalmology Department at the Maisonneuve-Rosemont Hospital (HMR), Dr. Hardy gathers teams of professionals to achieve numerous projects. Among them, the designation of the Ophthalmology Department at HMR as a University Center for Ophthalmology (CUO-HMR) by the Quebec Ministry of Health and Social Services in 2016 is a great example.
As Department Chair, Dr. Hardy demonstrates great support in the development of research and to the researchers. Her contribution by a judicious administration of philanthropic funds allows the creation of a diseased cornea bank as well as a vitreous and intraocular fluid bank, the development of a program in artificial intelligence and collaborative research with NASA through the Canadian Space Agency. She also establishes a postdoctoral fellowship grant program and more recently, she orchestrates the creation of a new departmental research Chair of 3,5 million of dollars.
Dr. Hardy is as well involved in different research projects and has a particular interest for dysthyroid orbitopathy. Since 2015, she joined a team of investigator at University of British Columbia in an international multicenter randomized controlled trial for treating patients with early progressive thyroid orbitopathy. Greatly appreciated by students, residents and fellows for her passionate and dynamic teaching, Dr. Hardy cumulates until now, more than thirty publications and numerous presentations at local, national and international scientific events.